Global post-operative pain management market research report, by pain type (acute pain, moderate pain, and severe pain), by products (non-steroidal anti-inflammatory drugs, antiepileptic drugs, opioids), application (cancer pain, arthritic pain, neuropathic pain, musculoskeletal pain, migraine, and other), by target area (back, legs, hand and arms and other) - forecast to 2027
ID: MRFR/Pharma/0738-HCR | February 2021 | Region: Global | 80 pages
Market scenario:
Post-operative pain management is a branch of the that deals with the minimizing the pain occur due to tissue injury together with muscle spasm to the patients after surgery. It is the branch of pain management. Global post- operative pain management market is growing steadily due to increasing demand for the pain control drugs and devices. Increasing number of surgeries across the globe and increasing prevalence of different diseases across the globe is the major factor for the growth of the market. Increasing age rises the possibility of the different complication, this increasing aging population is also has a synergistic impact of the growth of the market. According to the Centre for Disease Control and Prevention during last decade due to overdose of the analgesic drugs number of deaths has increased. Analgesic drugs are habit forming drugs and thus side effects of the treatment and habit forming nature of the drugs can hamper the growth of the market.
Global Post-operative pain management market was expected to grow at a CAGR of 5.4% during forecasted period 2017-2023.
Study objectives global post-operative pain management market
- Detail analysis of global post-operative pain management market with region specific growth and competitive analysis on the basis of major players present in the market
- Detail analysis of global post-operative pain management market and different drivers and restraints affecting the growth of the market
- Detailed analysis of the historical and forecasted market Analysis of the market on the basis of factors like- price analysis, supply chain analysis, porters five force analysis etc.
- To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global anesthesia delivery devices market.
- Detail analysis on the possible segments and sub segments of the market. And regional analysis of the market- America, Europe, Asia Pacific and Middle East and Africa.
- Insights on the major countries/regions in which these major industries is flourishing and to also identify the untapped regions which could be the potential markets in future
Figure 1- Global post-operative pain management market, by region
Key players for global post-operative pain management market
Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly (U.S), Pfizer (U.S), Johnson & Johnson (U.S), Purdue Pharma (U.S), Endo Pharmaceuticals Plc. (U.S), Forest Laboratories Inc. (U.S), GlaxoSmithKline Plc. (UK), F. Hoffmann-La Roche Ltd. (Switzerland), Baxter International Inc. (US), Valeant Pharmaceuticals International Inc. (Canada)
Segmentation
Global post-operative pain management market is segmented on the basis of pain type into acute pain, moderate pain and severe pain. On the basis of product they are segmented into non-steroidal anti-inflammatory drugs (NSAIDs), antiepileptic drugs, COX-2 inhibitors, opioids and other analgesics. On the basis of application they are segmented into cancer pain, arthritic pain, neuropathic pain, musculoskeletal pain, migraine and other and on the basis of target area they are back, legs, hand and arms and other.
Regional analysis
Geographically, America accounts the largest share for global post-operative pain management market. Increasing number of surgeries and rising burden of chronic diseases has led to the growth of this market in America. Europe commands second largest market which is followed by Asia Pacific. Asia Pacific is the fastest growing region for the market due to increasing prevalence of many diseases, increasing aging population and development in healthcare infrastructure in this region has provided fuel for the growth of the market.
Intended Audience
- Pharmaceutical companies
- Medical devices manufacturer and suppliers
- Research and Development (R&D) Companies
- Government Research Laboratories
- Independent Research Laboratories
- Government and Independent Regulatory Authorities
- Market Research and Consulting Service Providers
- Medical Research Laboratories
- Academic Medical Institutes and Universities
Market Assessment 
Annual reports, World Health Organization (WHO), White paper, the Centre for Disease Control and Prevention, Company Presentation The report for global post-operative pain management market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | 2027: Significant Value |
| CAGR | 5.4% (2017-2023) |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | pain type, products, application and target area |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly (U.S), Pfizer (U.S), Johnson & Johnson (U.S), Purdue Pharma (U.S), Endo Pharmaceuticals Plc. (U.S), Forest Laboratories Inc. (U.S), GlaxoSmithKline Plc. (UK), F. Hoffmann-La Roche Ltd. (Switzerland), Baxter International Inc. (US), Valeant Pharmaceuticals International Inc. (Canada) |
| Key Market Opportunities | Rising prevalence of different diseases across the globe |
| Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
The global post-operative pain management market is estimated to grow at 5.4% CAGR during the forecast period (2017-2023).
What are the major tailwinds pushing the growth of the global post-operative pain management market?
Increase in the global economy that is widening the access to the quality healthcare.
North America holds the largest share in the global post-operative pain management market followed by Europe and Asia Pacific, respectively.
Eli Lilly Company (US), Teva Pharmaceutical Industries Ltd. (Israel), Pfizer (US), Purdue Pharma (US), Johnson & Johnson (US), Endo Pharmaceuticals Plc. (US), GlaxoSmithKline Plc. (UK), Forest Laboratories Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Valeant Pharmaceuticals International Inc. (Canada), and Baxter International Inc. (US), are some of the major players operating in the global post-operative pain management market.
Strategic initiatives such as mergers & acquisitions, collaborations, expansion, and technology/ product launch are some of the growth strategies that players operating in the global post-operative pain management market adopt to gain a larger competitive advantage.
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porters Five Forces Model
4.2 Bargaining Power Of Suppliers
4.3 Bargaining Power Of Buyers
4.4 Threat Of New Entrants
4.5 Threat Of Substitutes
4.6 Intensity Of Rivalry
5. Global Post-Operative Pain Management Market, By Pain Type
5.1 Acute Pain
5.2 Moderate Pain
5.3 Severe Pain
6. Global Post-Operative Pain Management Market, By Product
6.1 Non-Steroidal Anti-Inflammatory Drugs (Nsaids)
6.2 Antiepileptic Drugs
6.3 Cox-2 Inhibitors
6.4 Opioids
6.5 Other Analgesics
7. Global Post-Operative Pain Management Market, By Application
7.1 Cancer Pain
7.2 Arthritic Pain
7.3 Neuropathic Pain
7.4 Musculoskeletal Pain
7.5 Migraine
7.6 Other
8. Global Post-Operative Pain Management Market, By Target Area
8.1 Back
8.2 Legs
8.3 Hand and Arms
8.4 Other
9. Global Post-Operative Pain Management Market, By Region
9.1 Introduction
9.2 America
9.2.1 North America
9.2.1.1 US
9.2.1.1 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.3 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic Of Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Oman
9.5.4 Kuwait
9.5.5 Qatar
9.5.6 Rest Of Middle East & Africa
10. Competitive Landscape
10.1 Major Strategies Adopted By Market Players
10.1.1 Strategic Partnership
10.1.2 Merger & Acquisition
11 Company Profile
11.1 Teva Pharmaceutical Industries Ltd.
11.1.1 Overview
11.1.2 Product Overview
11.1.3 Financials
11.1.4 Key Developments
11.2 Eli Lilly
11.2.1 Overview
11.2.2 Product Overview
11.2.3 Financials
11.2.4 Key Developments
11.3 Pfizer
11.3.1 Overview
11.3.2 Product Overview
11.3.3 Financials
11.3.4 Strategy
11.3.5 Key Development
11.4 Johnson & Johnson
11.4.1 Overview
11.4.2 Product Overview
11.4.3 Financials
11.4.4 Key Developments
11.5 Purdue Pharma
11.5.1 Overview
11.5.2 Product Overview
11.5.3 Financials
11.5.4 Key Developments
11.6 Others
11 Conclusion
12.1 Key Findings
12.1.1 From Ceo’s Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of Post-Operative Pain Management Industry
13 Appendix